Shionogi &
4507.TPharmaceutical
Filed as Shionogi & Co., Ltd. (2022-06–2026-09)
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥388.5bn | ¥363.3bn | ¥345.8bn | ¥369.5bn | ¥285.9bn | ¥261.0bn |
| Operating income | ¥133.3bn | ¥114.4bn | ¥109.0bn | ¥133.3bn | ¥96.0bn | ¥76.2bn |
| Ordinary income | ¥138.3bn | ¥109.1bn | ¥258.6bn | ¥135.0bn | ¥100.9bn | ¥81.7bn |
| Total assets | ¥1.78T | ¥941.2bn | ¥840.6bn | ¥768.1bn | ¥730.1bn | ¥617.1bn |
| Net assets / equity | ¥880.5bn | ¥791.8bn | ¥749.5bn | ¥612.9bn | ¥590.4bn | ¥536.4bn |
| EPS (basic) | ¥161.51 | ¥101.12 | ¥287.79r | ¥119.51r | ¥99.8r | ¥35.01r |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 15
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | AnnualAmended | 211 figures · EDINET |
| 2025-04-01 → 2026-03-31 | Annual | 211 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 82 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 211 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 82 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 226 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 106 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 106 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 241 figures · EDINET |
| 2020-04-01 → 2021-03-31 | AnnualAmended | 247 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 106 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 106 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 247 figures · EDINET |
21 more reports are still being processed.